Search Results

Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential signaling and drug discovery Symposium & Workshop - Brazil NEW April 1 - 3, 2025 | 2nd Peptide-Based Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities: Transforming receptor pharmacology - UK Australia GPCR Jobs NEW Open Postdoctoral position - Stanford University Structural Biologist - Confo Therapeutics Pharmacologist - Schrödinger Scientist - Biology - Superluminal Medicines Scientist I Cell Biology - Tectonic Therapeutic

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic

protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics

Courses On-demand GPCR courses created by leading experts, covering everything from basics to advanced therapeutics exclusive access to premium positions. 200+ Expert Talks Expert presentations across discovery and therapeutics

Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic

receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic

Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations

. 🗓️ Upcoming 4-Week Course: Development of GPCR Ligands as Therapeutic Drugs starting March 20 – April biotechs public Aikium's AI-Driven mRNA Engine Looks to Address Undruggable Disordered Proteins Tectonic Therapeutic - 21, 2025 | 2nd GPCR signaling and drug discovery Symposium & Workshop NEW April 2 - 3, 2025 | New therapeutic PhD Position GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic

students, and industry professionals eager to deepen their knowledge of GPCR signaling, pharmacology, and therapeutic Terry Kenakin Development of GPCR Ligands and Therapeutic Drugs Up March 20 – April 10 4 weeks x 1 hour

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics

understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic

GPCRs in the regulation of physiologic/pathologic function in the heart in an effort to uncover novel therapeutic

Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA; Division of Molecular Therapeutics, New York State

Optimization of Candidate Molecules GPCRs have been and arguably still are the most prolific and fertile therapeutic

Instructor Watch Now Terry Kenakin Decoding Drug Action Learn the four core drug properties to predict therapeutic

2022: Virtual Café Series launched - 16 episodes Sep 20, 2022: First contributor article published, Therapeutic

lesson: Target depletion vs. replenishment dynamics — how offset rates control exposure windows, shape therapeutic The result: inconsistent exposure, patchy activity, and sometimes, outright therapeutic failure. How target depletion and replenishment kinetics define the therapeutic window.

Biased signalling of Class B G protein-coupled receptor-targeted therapeutics Read More April 1, 2025

analysis, revealed nuanced roles of RGS4, RGS9, and RGSZ — not just as modulators but as potential therapeutic

University of Copenhagen, Copenhagen, Denmark. (2) Department of Psychiatry and Molecular Pharmacology and Therapeutics Columbia University Vagelos College of Physicians and Surgeons, New York, USA; Division of Molecular Therapeutics

Clements' work is primarily focused on translational developments of small molecule therapeutics, and

This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream

Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic

graduate student, he worked in the EuGEF Research Group to identify novel prognostic biomarkers and therapeutic Clearly, a new, less toxic therapeutic is needed.

Over the course of my graduate work, I gained experience with structural mass spectrometry and protein My postdoc work has made use of several techniques including various mass spectrometry approaches, single

Whether you’re decoding signaling pathways or designing the next generation of therapeutics, Revvity

. 💊 Therapeutic Potential : Understanding bias enables researchers to design drugs that target specific Kenakin challenges the traditional approach and encourages leveraging bias for better therapeutic outcomes